𝔖 Bobbio Scriptorium

✦ LIBER ✦

The search for a PCP antagonist. The discovery of potent PCP-like activity in a hexahydroindeno [2,1-c] pyridine series of compounds: Cantrell, B. E., L. G. Mendelsohn, D. D. Schoepp, J. D. Leander, R. B. Hermann and D. M. Zimmerman. Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285

Book ID: 113221027
Publisher: Elsevier Science
Year: 1987
Tongue: English
Weight: 105 KB
Volume: 28
Category: Article
ISSN: 0091-3057
DOI: 10.1016/0091-3057(87)90025-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The search for a PCP antagonist: Synthes

The search for a PCP antagonist: Synthesis and characterization of novel arylcyclohexylamine derivatives: Reel, J. K., L. G. Mendelsohn, J. D. Leander, D. M. Zimmerman, P. L. Ornstein, D. A. Evrard, D. D. Schoepp and R. B. Hermann. Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 111 KB

The search for a phencyclidine (PCP) ant

The search for a phencyclidine (PCP) antagonist. PCP-like effects of a series of substituted dioxolanes related to dexoxadrol: Ornstein, P. L., D. M. Zimmerman, D. J. Leander, L. Mendelsohn, J. K. Reel and D. A. Evrard. Lilly Research Laboratories, A Division of Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285

📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 123 KB

43 The discovery and general SAR studies

43 The discovery and general SAR studies of a novel class of potent non-nucleoside reverse transcriptase inhibitors: R. J. Ternansky1, J. M. Morin, Jr.1, C. Lopez1, C. J. Paget, Jr.1, F. W. Bell1, A. S. Cantrell1, S. R. Jaskunas1, C. L. Jordan1, M. D. Kinnick1, J. A. Palkowitz1, C. A. Parrish1, P. Pranc1, R. T. Vasileff1, S. J. West1, M. Hogberg2, P. Lind2, R. Noreen2, C. Sahlberg2, X.-X. Zhou2, L. Vrang2, C. Rydergard2, C. Ahgren2, B. Oberg2, and N. G. Johansson2. 1Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA; 2Medivir AB, Huddinge, Sweden

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 50 KB

71 SAR studies optimizing HIV-1 inhibiti

71 SAR studies optimizing HIV-1 inhibiting activities of LY73497, a new series of non-nucleoside inhibitors of reverse transcriptase: P. Engelhardt1, M. Hoberg1, J. Kangametsa1, P. Lind1, R. Noreen1, C. Sahlberg1, X.-X. Zhou1, L. Vrang1, H. Zhang1, B. Oberg1, N. G. Johansson1, F. W. Bell2, A. S. Cantrell2, J. A. Palkowitz2, S. R. Jaskunas2, C. L. Jordan2, M. D. Kinnick2, J. M. Morin, Jr.2, C. A. Parrish2, P. Pranc2, R. J. Ternansky2, R. T. Vasileff2, and S. J. West2. 1Medivir AB, Huddinge, Sweden; 2Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 62 KB